BioSpace News Archive

Inflammatory bowel disease (IBD) is an umbrella term for two conditions, Crohn’s disease and ulcerative colitis, that are characterized by chronic inflammation of the gastrointestinal (GI) tract. This chronic and prolonged inflammation results in damage to the GI tract.

Company recently received FDA approval for clinical trial; next generation device, SonoCloud-9, will soon be trialed in US

They will leverage Dicerna’s GalXC RNAi technology platform to explore more than 30 liver cell targets.

AbbVie’s blockbuster drug Humira just got another challenger to its share of the market in the United States when its patent expires in 2023.

The companies included on this list are the top ten companies headquartered in Biotech Bay based on 2018 revenue.

Three years after Novartis opened a $1 billion research & development facility in Shanghai, the company is shifting the focus of the site from drug discovery to commercial development.

Recipharm AB and Consort Medical plc have reached an agreement on the terms of a recommended cash offer by Recipharm Holdings Limited, a wholly-owned direct subsidiary of Recipharm, for Consort, a leading global drug delivery and device company and integrated contract development and manufacturing organisation

The Dubai Government Workshop, in collaboration with the Emirates Specialty Hospital, celebrated the World Diabetes Day, which falls on November 14 of every year, to help increase public awareness on treatment methods for diabetes and other chronic diseases.

OKRA Technologies, a leading provider of Artificial Intelligence driven analytics for global life sciences, announced they are joining the Veeva Technology Partnership Program and will be making their proprietary AI outputs available to Veeva CRM customers.

opics cover institutional review board (IRB) administration, research oversight, and research ethics